These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7129295)

  • 1. [Treatment of ankylosing spondylitis with slow-release diclofenac sodium in a single daily dose].
    Droste U; Siemens P
    Fortschr Med; 1982 Aug; 100(29):1374-6. PubMed ID: 7129295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group.
    Batlle-Gualda E; Figueroa M; Ivorra J; Raber A
    J Rheumatol; 1996 Jul; 23(7):1200-6. PubMed ID: 8823693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled comparative trial of Butacote and fenclofenac in the treatment of ankylosing spondylitis.
    Thompson M; Akyol MS
    J Int Med Res; 1977; 5 Suppl 2():96-9. PubMed ID: 334611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diclofenac-Na in ankylosing spondylitis].
    Manz G; Franke M
    Fortschr Med; 1977 Jul; 95(26):1706-8. PubMed ID: 885458
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J; Klopsch T; Richter M; Kapelle A; Rudwaleit M; Schwank S; Regourd E; May M
    Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open study of a diclofenac sodium prolonged-release in patients suffering from coxarthrosis.
    Varese C; Palazzini A
    Eur Rev Med Pharmacol Sci; 1997; 1(1-3):57-62. PubMed ID: 9444800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and tolerability of diclofenac gel (Voltarol Emulgel) and felbinac gel (Traxam) in the treatment of soft tissue injuries.
    Bouchier-Hayes TA; Rotman H; Darekar BS
    Br J Clin Pract; 1990 Aug; 44(8):319-20. PubMed ID: 2206836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once daily dose treatment with a non-steroidal anti-rheumatic drug (diclofenac) in osteoarthrosis.
    Schubiger BI; Ciccolunghi SN; Tanner K
    J Int Med Res; 1980; 8(2):167-74. PubMed ID: 6989687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of osteoarthritis with a 150 mg prolonged-release of diclofenac sodium.
    Arcangeli P; Andreotti L; Palazzini E
    Riv Eur Sci Med Farmacol; 1996; 18(5-6):217-23. PubMed ID: 9177625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diclofenac sodium: blood concentration of the slow-release form and influence on the metabolism of kallikrein.
    Gross W; Kroh J; Krebs A; Zöller H
    Arzneimittelforschung; 1984; 34(10):1327-9. PubMed ID: 6335038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olsalazine in ankylosing spondylitis: a pilot study.
    Chapman CM; Zwillich SH
    J Rheumatol; 1994 Sep; 21(9):1699-701. PubMed ID: 7799352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis.
    Ejstrup L; Peters ND
    Dan Med Bull; 1985 Aug; 32(4):231-3. PubMed ID: 4042697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the efficacy of a single daily administration of slow-release diclofenac in the treatment of degenerative and non-degenerative arthropathies. Multicenter study concerning 643 patients].
    Baroni L; Borghi C; Trombetta N
    Clin Ter; 1984 Apr; 109(2):155-63. PubMed ID: 6234125
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative responsiveness of 3 functional indices in ankylosing spondylitis.
    Ruof J; Sangha O; Stucki G
    J Rheumatol; 1999 Sep; 26(9):1959-63. PubMed ID: 10493677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab in severe active ankylosing spondylitis with spinal ankylosis.
    Cheung PP; Tymms KE; Wilson BJ; Shadbolt B; Brook AS; Dorai Raj AK; Khoo KB
    Intern Med J; 2008 Jun; 38(6):396-401. PubMed ID: 18336538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis.
    Wanders AJ; Gorman JD; Davis JC; Landewe RB; van der Heijde DM
    Arthritis Rheum; 2004 Feb; 51(1):1-8. PubMed ID: 14872448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis.
    Villa Alcázar LF; de Buergo M; Rico Lenza H; Montull Fruitós E
    J Rheumatol; 1996 Jul; 23(7):1194-9. PubMed ID: 8823692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of specific spinal mobilization for patients with ankylosing spondylitis evaluated by quantitative assessments and patient interviews.
    Mengshoel AM; Robinson HS
    Disabil Rehabil; 2008; 30(5):355-64. PubMed ID: 17852208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial.
    Gonzalez-Lopez L; Garcia-Gonzalez A; Vazquez-Del-Mercado M; Muñoz-Valle JF; Gamez-Nava JI
    J Rheumatol; 2004 Aug; 31(8):1568-74. PubMed ID: 15290737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.